Cardiac injury is associated with mortality and critically ill pneumonia in COVID-19: A meta-analysis
- PMID: 32331955
- PMCID: PMC7166308
- DOI: 10.1016/j.ajem.2020.04.052
Cardiac injury is associated with mortality and critically ill pneumonia in COVID-19: A meta-analysis
Abstract
Background: In this systematic review and meta-analysis, we aimed to explore the association between cardiac injury and mortality, the need for intensive care unit (ICU) care, acute respiratory distress syndrome (ARDS), and severe coronavirus disease 2019 (COVID-19) in patients with COVID-19 pneumonia.
Methods: We performed a comprehensive literature search from several databases. Definition of cardiac injury follows that of the included studies, which includes highly sensitive cardiac troponin I (hs-cTnl) >99th percentile.The primary outcome was mortality, and the secondary outcomes were ARDS, the need for ICU care, and severe COVID-19. ARDS and severe COVID-19 were defined per the World Health Organization (WHO) interim guidance of severe acute respiratory infection (SARI) of COVID-19.
Results: There were a total of 2389 patients from 13 studies. This meta-analysis showed that cardiac injury was associated with higher mortality (RR 7.95 [5.12, 12.34], p < 0.001; I2: 65%). Cardiac injury was associated with higher need for ICU care (RR 7.94 [1.51, 41.78], p = 0.01; I2: 79%), and severe COVID-19 (RR 13.81 [5.52, 34.52], p < 0.001; I2: 0%). The cardiac injury was not significant for increased risk of ARDS (RR 2.57 [0.96, 6.85], p = 0.06; I2: 84%). The level of hs-cTnI was higher in patients with primary + secondary outcome (mean difference 10.38 pg/mL [4.44, 16.32], p = 0.002; I2: 0%).
Conclusion: Cardiac injury is associated with mortality, need for ICU care, and severity of disease in patients with COVID-19.
Keywords: COVID-19; Cardiac injury; Coronavirus; Mortality; Troponin.
© 2020 Elsevier Inc. All rights reserved.
Figures
Comment in
-
Cardiac injury, ARDS and COVID-19 meta-analysis validity - Correspondence in response to Santoso et al.Am J Emerg Med. 2021 Apr;42:252. doi: 10.1016/j.ajem.2020.06.028. Epub 2020 Jun 27. Am J Emerg Med. 2021. PMID: 32641263 Free PMC article. No abstract available.
-
The authors reply: Study selection for meta-analyses.Am J Emerg Med. 2021 Apr;42:253. doi: 10.1016/j.ajem.2020.06.035. Epub 2020 Jun 25. Am J Emerg Med. 2021. PMID: 32641266 Free PMC article. No abstract available.
References
-
- World Health Organization Novel coronavirus – China. 2020. https://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en/
-
- World Health Organization Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. 2020. https://www.who.int/csr/sars/country/table2004_04_21/en/
-
- World Health Organization Middle East respiratory syndrome coronavirus (MERS-CoV) 2020. https://www.who.int/emergencies/mers-cov/en/
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
